Latest podcasts

 

Time-limited venetoclax and ibrutinib for patients with R/R CLL and undetectable MRD

Prof. Carsten Niemann, Department of Clinical Medicine, University of Copenhagen, Denmark
 

Talha Munir about ibrutinib plus venetoclax vs chlorambucil plus obinutuzumab for CLL patients

(now playing ...)
Dr. Talha Munir, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
All podcasts
X